FluoroPharma to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
BOSTON, Jan. 13, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical (OTCBB:FPMI), a biopharmaceutical company engaged in the discovery and development of proprietary PET imaging products, today announced that Thijs Spoor, President & CEO of FluoroPharma Medical, will present at Noble Financial Capital Markets' Eight Annual Equity Conference.